X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (28729) 28729
Book Review (4698) 4698
Newsletter (1494) 1494
Publication (1250) 1250
Newspaper Article (1035) 1035
Magazine Article (341) 341
Trade Publication Article (109) 109
Book Chapter (92) 92
Conference Proceeding (90) 90
Web Resource (40) 40
Dissertation (23) 23
Transcript (23) 23
Reference (8) 8
Book / eBook (5) 5
Government Document (4) 4
Report (3) 3
Journal / eJournal (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (23643) 23643
humans (20219) 20219
aspirin (17730) 17730
male (12809) 12809
female (11691) 11691
aspirin - administration & dosage (9092) 9092
middle aged (7559) 7559
aged (6511) 6511
aspirin - therapeutic use (6427) 6427
adult (5623) 5623
animals (5337) 5337
abridged index medicus (5336) 5336
risk factors (4241) 4241
aspirin - pharmacology (4134) 4134
aspirin - adverse effects (3969) 3969
platelet aggregation inhibitors - administration & dosage (3716) 3716
cardiac & cardiovascular systems (3479) 3479
prevention (3456) 3456
platelet aggregation inhibitors - therapeutic use (3401) 3401
treatment outcome (3141) 3141
dosage and administration (3110) 3110
drug therapy, combination (3051) 3051
pharmacology & pharmacy (3027) 3027
ticlopidine - analogs & derivatives (2996) 2996
clopidogrel (2853) 2853
drug therapy (2665) 2665
time factors (2608) 2608
rats (2539) 2539
risk (2463) 2463
dose-response relationship, drug (2412) 2412
research (2389) 2389
peripheral vascular disease (2262) 2262
stroke (2252) 2252
care and treatment (2216) 2216
medicine, general & internal (2197) 2197
platelet aggregation inhibitors - adverse effects (1986) 1986
low-dose aspirin (1973) 1973
hematology (1922) 1922
administration, oral (1919) 1919
platelet aggregation - drug effects (1856) 1856
health aspects (1845) 1845
aged, 80 and over (1840) 1840
analysis (1794) 1794
therapy (1782) 1782
mortality (1776) 1776
thrombosis (1770) 1770
ticlopidine - administration & dosage (1754) 1754
nonsteroidal antiinflammatory drugs (1709) 1709
prospective studies (1655) 1655
double-blind method (1638) 1638
heart attacks (1598) 1598
surgery (1597) 1597
cardiovascular disease (1582) 1582
ticlopidine - therapeutic use (1554) 1554
anticoagulants (1539) 1539
anti-inflammatory agents, non-steroidal - administration & dosage (1506) 1506
myocardial-infarction (1468) 1468
pregnancy (1449) 1449
anti-inflammatory agents, non-steroidal - adverse effects (1402) 1402
anticoagulants - therapeutic use (1400) 1400
follow-up studies (1393) 1393
anticoagulants - administration & dosage (1389) 1389
medicine & public health (1374) 1374
retrospective studies (1334) 1334
antiplatelet therapy (1323) 1323
cardiology (1323) 1323
blood platelets - drug effects (1304) 1304
acute coronary syndromes (1259) 1259
blood platelets (1215) 1215
inhibition (1214) 1214
medical research (1201) 1201
disease (1199) 1199
drug administration schedule (1183) 1183
anti-inflammatory agents, non-steroidal - therapeutic use (1177) 1177
drugs (1173) 1173
adolescent (1167) 1167
platelet aggregation inhibitors - pharmacology (1156) 1156
warfarin (1154) 1154
mice (1142) 1142
clinical trials (1139) 1139
percutaneous coronary intervention (1129) 1129
patients (1122) 1122
complications and side effects (1116) 1116
clinical trials as topic (1105) 1105
coronary heart disease (1088) 1088
studies (1086) 1086
inflammation (1082) 1082
cardiac patients (1067) 1067
risk assessment (1067) 1067
trial (1043) 1043
cancer (1032) 1032
stents (1026) 1026
cardiovascular diseases (1021) 1021
hemorrhage - chemically induced (1000) 1000
randomized controlled trials as topic (991) 991
drug interactions (959) 959
stroke - prevention & control (957) 957
internal medicine (950) 950
myocardial infarction - drug therapy (949) 949
cardiovascular (937) 937
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (29530) 29530
German (674) 674
French (348) 348
Japanese (263) 263
Russian (248) 248
Spanish (161) 161
Italian (112) 112
Polish (89) 89
Chinese (88) 88
Danish (52) 52
Norwegian (38) 38
Dutch (35) 35
Swedish (31) 31
Czech (27) 27
Hungarian (25) 25
Portuguese (21) 21
Turkish (16) 16
Korean (11) 11
Ukrainian (9) 9
Romanian (7) 7
Bulgarian (6) 6
Hebrew (6) 6
Serbian (6) 6
Slovak (6) 6
Lithuanian (5) 5
Croatian (4) 4
Finnish (4) 4
Persian (3) 3
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Medicine, The, ISSN 0002-9343, 2012, Volume 125, Issue 9, pp. 882 - 887.e1
Abstract Objective Combination therapy, specifically with aspirin, cholesterol and blood pressure-lowering drugs, substantially reduces the risk of coronary... 
Internal Medicine | Adherence | Prevention | Cardiovascular disease | PERSISTENCE | ACUTE CORONARY SYNDROMES | CONVERTING ENZYME-INHIBITORS | SECONDARY PREVENTION | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | STATIN THERAPY | ACUTE MYOCARDIAL-INFARCTION | BETA-BLOCKERS | MEDICATION ADHERENCE | ARTERY-DISEASE | Drug Costs | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Medication Adherence - statistics & numerical data | Cardiovascular Agents - administration & dosage | Age Factors | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Antihypertensive Agents - administration & dosage | Secondary Prevention - methods | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Aspirin - administration & dosage | Drug Prescriptions - statistics & numerical data | Self Administration | Time Factors | Anticholesteremic Agents - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Calcium Channel Blockers - administration & dosage | Primary Prevention - methods | Sodium Chloride Symporter Inhibitors - administration & dosage | Myocardial Infarction - prevention & control | Adrenergic beta-Antagonists - administration & dosage | Angiotensin Receptor Antagonists - administration & dosage | Research | Patient compliance | Coronary heart disease | Disease prevention | Prescription drugs | Drug therapy | Meta-analysis | Index Medicus | Abridged Index Medicus | Drugs | Myocardial infarction | Aspirin | Side effects | Enzyme inhibitors | Risk reduction | Age | Statins
Journal Article
European Journal of Preventive Cardiology, ISSN 2047-4873, 7/2015, Volume 22, Issue 7, pp. 920 - 930
Background Most individuals at high cardiovascular disease (CVD) risk worldwide do not receive any or optimal preventive drugs. We aimed to determine whether... 
blood pressure | Cardiovascular disease | cholesterol | polypill | adherence | prevention | NON-INDIGENOUS PEOPLE | DRUG-THERAPY | DESIGN | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | RATIONALE | MEDICATION NONADHERENCE | IMPACT | GAP | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Hyperlipidemias - blood | Prospective Studies | Tablets | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Male | Aspirin - administration & dosage | Hyperlipidemias - diagnosis | Polypharmacy | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | General Practice | Sodium Chloride Symporter Inhibitors - administration & dosage | Cardiovascular Diseases - blood | Female | Adrenergic beta-1 Receptor Antagonists - administration & dosage | Blood Pressure - drug effects | Atenolol - administration & dosage | Hypertension - diagnosis | Hyperlipidemias - complications | Cardiovascular Diseases - diagnosis | Lisinopril - administration & dosage | Cardiovascular Diseases - etiology | Cardiovascular Diseases - physiopathology | Administration, Oral | Simvastatin - administration & dosage | Hyperlipidemias - drug therapy | Risk Factors | Drugs, Generic - administration & dosage | Treatment Outcome | Hydrochlorothiazide - administration & dosage | Biomarkers - blood | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Hypertension - physiopathology | Primary Prevention - methods | Hypertension - complications | Aged | Australia | Drug Combinations | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2014, Volume 371, Issue 23, pp. 2155 - 2166
Patients who had received a drug-eluting stent and then dual antiplatelet therapy for 12 months were randomly assigned to 18 more months of therapy or aspirin... 
TRIALS | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | MULTICENTER | CLOPIDOGREL | TICAGRELOR | THROMBOSIS | RATIONALE | PREVENTION | ASPIRIN | CLINICAL-OUTCOMES | Piperazines - administration & dosage | Prasugrel Hydrochloride | Thiophenes - adverse effects | Humans | Middle Aged | Male | Thiophenes - administration & dosage | Aspirin - administration & dosage | Incidence | Time Factors | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Myocardial Ischemia - mortality | Thrombosis - prevention & control | Drug Therapy, Combination | Myocardial Ischemia - epidemiology | Platelet Aggregation Inhibitors - adverse effects | Drug-Eluting Stents | Drug Administration Schedule | Piperazines - adverse effects | Ticlopidine - analogs & derivatives | Myocardial Ischemia - therapy | Aged | Hemorrhage - chemically induced | Aggregation | Treatment outcome | Care and treatment | Usage | Blood platelets | Analysis | Drug-eluting stents | Dosage and administration | Cardiovascular diseases | Thrombosis | Health aspects | Blood clot | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Drug delivery | Patients | Bleeding | Clinical outcomes | Cerebrovascular system | Coronary vessels | Implants | Clopidogrel | Drug therapy | Stents | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 05/2009, Volume 53, Issue 21, pp. 1965 - 1972
Journal Article
Stroke, ISSN 0039-2499, 06/2013, Volume 44, Issue 6, pp. 1676 - 1681
Background and Purpose-To estimate the cost-effectiveness of stroke prevention in patients with nonvalvular atrial fibrillation by using novel oral... 
Intracranial hemorrhage | Stroke | Anticoagulation | Markov model | Cost-effectiveness | Atrial fibrillation | cost-effectiveness | ANTICOAGULATION CONTROL | QUALITY | anticoagulation | stroke | ASPIRIN | CLINICAL NEUROLOGY | PROPHYLAXIS | atrial fibrillation | HEART-DISEASE | BENEFIT | THERAPY | intracranial hemorrhage | SCORES | PERIPHERAL VASCULAR DISEASE | UPDATE | UTILITY | Thiophenes - therapeutic use | Markov Chains | Pyrazoles - therapeutic use | Anticoagulants - administration & dosage | United States | Humans | Anticoagulants - economics | Thiophenes - administration & dosage | Warfarin - economics | Benzimidazoles - economics | Dabigatran | Morpholines - economics | Warfarin - administration & dosage | Warfarin - therapeutic use | Dose-Response Relationship, Drug | Pyridones - administration & dosage | Rivaroxaban | Benzimidazoles - administration & dosage | beta-Alanine - economics | Stroke - epidemiology | Thiophenes - economics | Pyridones - economics | beta-Alanine - analogs & derivatives | Morpholines - therapeutic use | Benzimidazoles - therapeutic use | Quality-Adjusted Life Years | Stroke - prevention & control | Administration, Oral | Morpholines - administration & dosage | Risk Factors | Atrial Fibrillation - complications | beta-Alanine - administration & dosage | beta-Alanine - therapeutic use | Anticoagulants - therapeutic use | Models, Statistical | Pyrazoles - economics | Pyrazoles - administration & dosage | Cost-Benefit Analysis | Aged | Pyridones - therapeutic use | Cohort Studies | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2012, Volume 367, Issue 22, pp. 2100 - 2109
Journal Article
CMAJ, ISSN 0820-3946, 11/2011, Volume 183, Issue 16, pp. 1835 - 1843
Background: Patients prescribed antiplatelet treatment to prevent recurrent acute myocardial infarction are often also given a selective serotonin reuptake... 
DEPRESSION | ESOMEPRAZOLE | MEDICINE, GENERAL & INTERNAL | ANTIDEPRESSANTS | CLOPIDOGREL | EVENTS | PROGNOSIS | DRUGS | ELDERLY-PATIENTS | ASPIRIN | Age Factors | Anemia - epidemiology | Angioplasty | Humans | Middle Aged | Citalopram - adverse effects | Male | Risk | Secondary Prevention | Sertraline - adverse effects | Peptic Ulcer - epidemiology | Adrenal Cortex Hormones - therapeutic use | Renal Insufficiency - epidemiology | Aspirin - administration & dosage | Paroxetine - adverse effects | Paroxetine - administration & dosage | Fluvoxamine - administration & dosage | Canada - epidemiology | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Retrospective Studies | Drug Therapy, Combination | Heart Failure - epidemiology | Fluoxetine - adverse effects | Platelet Aggregation Inhibitors - adverse effects | Hypoglycemic Agents - therapeutic use | Hemorrhage - epidemiology | Risk Factors | Serotonin Uptake Inhibitors - adverse effects | Anticoagulants - therapeutic use | Antihypertensive Agents - therapeutic use | Fluvoxamine - adverse effects | Ticlopidine - analogs & derivatives | Citalopram - administration & dosage | Sertraline - administration & dosage | Serotonin Uptake Inhibitors - administration & dosage | Fluoxetine - administration & dosage | Sex Factors | Aged | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Neoplasms - epidemiology | Cohort Studies | Aggregation | Complications and side effects | Blood platelets | Patient outcomes | Serotonin uptake inhibitors | Dosage and administration | Drug therapy | Hemorrhage | Heart attack | Risk factors | Studies | Side effects | Heart attacks | Inhibitor drugs | Index Medicus | Abridged Index Medicus | Research
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2014, Volume 9, Issue 6, pp. e100478 - e100478
Journal Article
International Journal of Hematology, ISSN 0925-5710, 11/2017, Volume 106, Issue 5, pp. 591 - 611
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s12185-017-2330-1 Byline:... 
Medicine & Public Health | Hematology | Oncology | RISK ESSENTIAL THROMBOCYTHEMIA | PLUS INTERFERON-ALPHA | DIAGNOSED CHRONIC-PHASE | COMPLETE MOLECULAR REMISSION | STANDARD-DOSE IMATINIB | TYROSINE KINASE INHIBITOR | PATIENTS RECEIVING IMATINIB | STEM-CELL TRANSPLANTATION | HEMATOLOGY | CHRONIC MYELOID-LEUKEMIA | INTERNATIONAL WORKING GROUP | Prognosis | Humans | Imidazoles - administration & dosage | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Risk | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - therapy | Antineoplastic Agents - administration & dosage | Quinolines - administration & dosage | Myeloproliferative Disorders - genetics | Aspirin - administration & dosage | Nitriles - administration & dosage | Blood Transfusion | Pyridazines - administration & dosage | Quinazolines - administration & dosage | Aniline Compounds - administration & dosage | Myeloproliferative Disorders - therapy | Pyrimidines - administration & dosage | Japan | Myeloproliferative Disorders - classification | Phlebotomy | Hematopoietic Stem Cell Transplantation | Hydroxyurea - administration & dosage | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - classification | Pyrazoles - administration & dosage | Algorithms | Dasatinib - administration & dosage | Protein Kinase Inhibitors - therapeutic use | Protein-Tyrosine Kinases - antagonists & inhibitors | Tumors | Myeloid leukemia | Leukemia | Chronic myeloid leukemia | Lymphoid tissue | Tissues | Neoplasms | Hemopoiesis | Index Medicus
Journal Article